Accéder au contenu
Merck

IGF2BP3 Modulates the Interaction of Invasion-Associated Transcripts with RISC.

Cell reports (2016-05-24)
Hanane Ennajdaoui, Jonathan M Howard, Timothy Sterne-Weiler, Fereshteh Jahanbani, Doyle J Coyne, Philip J Uren, Marija Dargyte, Sol Katzman, Jolene M Draper, Andrew Wallace, Oscar Cazarez, Suzanne C Burns, Mei Qiao, Lindsay Hinck, Andrew D Smith, Masoud M Toloue, Benjamin J Blencowe, Luiz O F Penalva, Jeremy R Sanford
RÉSUMÉ

Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) expression correlates with malignancy, but its role(s) in pathogenesis remains enigmatic. We interrogated the IGF2BP3-RNA interaction network in pancreatic ductal adenocarcinoma (PDAC) cells. Using a combination of genome-wide approaches, we have identified 164 direct mRNA targets of IGF2BP3. These transcripts encode proteins enriched for functions such as cell migration, proliferation, and adhesion. Loss of IGF2BP3 reduced PDAC cell invasiveness and remodeled focal adhesion junctions. Individual nucleotide resolution crosslinking immunoprecipitation (iCLIP) revealed significant overlap of IGF2BP3 and microRNA (miRNA) binding sites. IGF2BP3 promotes association of the RNA-induced silencing complex (RISC) with specific transcripts. Our results show that IGF2BP3 influences a malignancy-associated RNA regulon by modulating miRNA-mRNA interactions.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anti-Ago2 Antibody, clone 9E8.2, ascites fluid, clone 9E8.2, Upstate®